E.S. Barr & Co’s Oracle ORCL Stock Holding History

E.S. Barr & Co’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,250	Closed	-$201K	–	95
2017 Q4	$201K	Buy	+4,250	New	+$208K	0.02%	91

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

E.S. Barr & Co's ORCL Position: Q1 2018 in Review

E.S. Barr & Co sold out of Oracle (ORCL) in Q1 2018, closing a stake of 4,250 shares — an estimated $201K sold.

E.S. Barr & Co first reported a position in ORCL in Q4 2017 and held it in 1 quarter. The position peaked at $201K in Q4 2017. 1,752 funds tracked by Wall St. Rank hold ORCL as of Q1 2018.

E.S. Barr & Co reported no remaining Oracle position as of Q1 2018 after selling out during the quarter.
E.S. Barr & Co sold 4,250 Oracle shares in Q1 2018, an estimated $201K.
E.S. Barr & Co first reported a position in Oracle in Q4 2017 and held it in 1 quarter.
E.S. Barr & Co's Oracle position peaked at $201K in Q4 2017.
1,752 funds tracked by Wall St. Rank held Oracle as of Q1 2018.

Based on E.S. Barr & Co's 13F filing for Q1 2018, filed 15 May 2018.